The design and development of the Scale of the Impact of Perceived Symptoms in Schizophrenia, the PRISS scale (Patient-Reported Impact of Symptoms in Schizophrenia Scale), arose from the growing interest in understanding how patients feel and the impact their symptoms have on their daily lives, and the important contribution of this to both clinical outcomes and quality of care. It is therefore proposed as a Patient-Reported Outcome measure (Patient-Reported Outcomes, PRO). The PRISS scale is specifically aimed at people diagnosed with schizophrenia.
The PRISS scale is the result of a research project funded by the Instituto de Salud Carlos III (PI16/00647), belonging to the Ministry of Health, Social Services and Equality. The study has been coordinated by the University of Málaga, a center belonging to the Biomedical Research Institute of Málaga. The research team is multidisciplinary and belongs to academic and healthcare centers located in different parts of Spain: the Mental Health Clinical Management Unit of the Puerto Real University Hospital (Cádiz), the Girona Biomedical Research Institute, the Mental Health Clinical Management Unit of the Málaga Regional Hospital, Parc Sanitari Sant Joan de Déu (Barcelona), the University of Cádiz, and the University of Canberra (Australia).
This study was approved by the Provincial Research Ethics Committee of Málaga on 21/07/2016.